More About Lori Reilly
During a panel on drug costs, Reilly explains how the profits from drug sales allow for manufacturers to recoup the high R&D costs of new products, as well as contribute to facilitating further innovations and breakthroughs. (Reilly speaks at 26:16)
Profile of Lori Reilly’s work as executive vice president for policy and research at the Pharmaceutical Research and Manufacturers of America (PhRMA).
Pharmaceutical Research and Manufacturers of America's overview of the cost and value of medicines.